Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
GRAIL is a US-based biotechnology company dedicated to the early detection of cancer. It develops advanced liquid biopsy blood tests for multi-cancer detection to improve diagnosis and offer patients better treatment opportunities. The focus is on innovative oncology diagnostics.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
GRAIL is scheduled to report its next quarterly earnings on 11/18/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
GRAIL last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -2.56 USD.
Across its last 4 earnings reports, GRAIL stock moved by ±20.5% on average the following day. The largest reaction was -50.6% on 02/19/2026; 2 of 4 reactions were positive.
GRAIL has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.